With acute myeloid leukemia classification overseen by 3 separate guidelines, Firas El Chaer, MD, is working to bring order to the chaos.
Category: Oncology Innovations
Craig Portell, MD, shares the future clinical impact of his work, the complexity and diversity of lymphoma subtypes, and what drew him to UVA Health.
This research looks to redefine the standard of care for breast cancer in older women.
In this Q&A, researchers share how focused ultrasound is becoming a game-changer for cancer and what to watch for next.
Shayan Moosa, MD, shares how this therapy holds promise for glioblastoma and other brain cancers and disorders.
Learn how Robert Driecer, MD, helps translate research findings into better treatments for his patients with urologic cancers.
Non-muscle invasive bladder cancer has a high recurrence rate, but this treatment offers an additional way to stop it from progressing to a deadlier muscle invasive cancer.
Karen Ballen, MD, international expert in stem cell transplant and alternative donor transplant (transplant from donors that are not perfect matches), explains how it's possible.
UVA Health is among the first in the U.S. to offer BiTE therapy to small cell lung cancer patients in the outpatient setting.
Targeting the transcription factors that drive certain cancers could lead to more effective, less toxic treatments.